''Americans for Safe Access v. Drug Enforcement Administration'' was a case in which the U.S. Court of Appeals for the D.C. Circuit held that the

DEA The Drug Enforcement Administration (DEA; ) is a United States federal law enforcement agency under the U.S. Department of Justice tasked with combating drug trafficking and distribution within the U.S. It is the lead agency for domestic en ...

's denial of a petition by plaintiff

Americans for Safe Access Americans for Safe Access (ASA), based in Washington, D.C., is a member-based organization working to ensure safe and legal access to cannabis for therapeutic uses and research. Americans for Safe Access works in partnership with local, state, an ...

for

removal of cannabis from Schedule I of the Controlled Substances Act In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act is a proposed legal and administrative change in cannabis-related law at the federal level. It has been proposed repeatedly since 1972. The category ...

survives review under the deferential

arbitrary and capricious In law, the standard of review is the amount of deference given by one court (or some other appellate tribunal) in reviewing a decision of a lower court or tribunal. A low standard of review means that the decision under review will be varied or o ...

standard. requires that

cannabis ''Cannabis'' () is a genus of flowering plants in the family Cannabaceae. The number of species within the genus is disputed. Three species may be recognized: '' Cannabis sativa'', '' C. indica'', and '' C. ruderalis''. Alternative ...

be found to have no "currently accepted medical use" in order to remain in Schedule I. This DEA, pursuant to regulations that the court had approved in ''

Alliance for Cannabis Therapeutics v. DEA An alliance is a relationship among people, groups, or states that have joined together for mutual benefit or to achieve some common purpose, whether or not explicit agreement has been worked out among them. Members of an alliance are called ...

'', interpreted this to require "adequate and well-controlled studies proving efficacy" in order for cannabis to be removed from Schedule I. The court deferred to the agency's interpretation and found that substantial evidence supported the DEA's determination that such studies do not exist. This case was the third attempt to get the D.C. Circuit to order that cannabis be rescheduled.

References

{{Cannabis in the United States Controlled Substances Act Cannabis law in the United States 2012 in cannabis

Further reading

References